FR2316943A1 - Pyrrolidones et medicaments qui en contiennent - Google Patents

Pyrrolidones et medicaments qui en contiennent

Info

Publication number
FR2316943A1
FR2316943A1 FR7619563A FR7619563A FR2316943A1 FR 2316943 A1 FR2316943 A1 FR 2316943A1 FR 7619563 A FR7619563 A FR 7619563A FR 7619563 A FR7619563 A FR 7619563A FR 2316943 A1 FR2316943 A1 FR 2316943A1
Authority
FR
France
Prior art keywords
pyrrolidons
products containing
medicinal products
medicinal
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7619563A
Other languages
English (en)
Other versions
FR2316943B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2316943A1 publication Critical patent/FR2316943A1/fr
Application granted granted Critical
Publication of FR2316943B1 publication Critical patent/FR2316943B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
FR7619563A 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent Granted FR2316943A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2316943A1 true FR2316943A1 (fr) 1977-02-04
FR2316943B1 FR2316943B1 (fr) 1978-11-03

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7619563A Granted FR2316943A1 (fr) 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent

Country Status (14)

Country Link
JP (1) JPS525764A (fr)
AT (1) AT365575B (fr)
BE (1) BE843505A (fr)
CH (1) CH623809A5 (fr)
DE (1) DE2528664A1 (fr)
DK (1) DK287476A (fr)
ES (1) ES449095A1 (fr)
FR (1) FR2316943A1 (fr)
GB (1) GB1553595A (fr)
IL (1) IL49916A0 (fr)
LU (1) LU75235A1 (fr)
NL (1) NL7606773A (fr)
SE (1) SE7607331L (fr)
ZA (1) ZA763802B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2369260A1 (fr) * 1976-08-06 1978-05-26 Pfizer 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
WO2001046140A1 (fr) 1999-12-22 2001-06-28 Pfizer Products Inc. Agonistes selectifs au recepteur ep4 dans le traitement de l'osteoporose
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
SK5562003A3 (en) 2000-11-27 2004-08-03 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis
DK1408961T3 (da) 2001-07-16 2007-11-05 Hoffmann La Roche 2 pyrrolidon-derivater som prostanoide agonister
KR20040015364A (ko) 2001-07-16 2004-02-18 에프. 호프만-라 로슈 아게 Ｅｐ4 수용체 작용물질로서의 프로스타글란딘 유사체
IL159996A0 (en) 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
BR0308738A (fr) * 2002-03-18 2005-01-11
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
CN1735597A (zh) 2003-01-10 2006-02-15 霍夫曼-拉罗奇有限公司 作为前列腺素激动剂的2－哌啶酮衍生物
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2014015247A1 (fr) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Composés de difluorolactame comme agonistes sélectifs du récepteur ep4, destinés à être utilisés dans le traitement de maladies et d'affections médiées par ep4
EP3235817B1 (fr) 2013-03-15 2018-12-12 Cayman Chemical Company, Incorporated Composés de lactamine en tant qu'agonistes sélectifs du récepteur ep4 destinés à être utilisés dans le traitement des maladies et affections transmises par l'ep4
AU2014229065B2 (en) 2013-03-15 2017-03-09 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOLUME 85 1976 123 751 H CITE JA - A - 76 01 461 TANABE SEIYAKU CO. ) *
TETRAHEDRON LETTERS, NO. 51 1975 , PAGES 4599 - 4602 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2369260A1 (fr) * 1976-08-06 1978-05-26 Pfizer 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation

Also Published As

Publication number Publication date
SE7607331L (sv) 1976-12-28
ES449095A1 (es) 1977-12-16
NL7606773A (nl) 1976-12-29
JPS525764A (en) 1977-01-17
FR2316943B1 (fr) 1978-11-03
LU75235A1 (fr) 1977-03-16
DK287476A (da) 1976-12-28
ZA763802B (en) 1977-05-25
IL49916A0 (en) 1976-08-31
CH623809A5 (en) 1981-06-30
AT365575B (de) 1982-01-25
DE2528664A1 (de) 1977-01-13
BE843505A (fr) 1976-12-28
GB1553595A (en) 1979-09-26
ATA467976A (de) 1981-06-15

Similar Documents

Publication Publication Date Title
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
BE860877A (fr) Spirolactones steroidiques et medicaments qui en contiennent
FR2282892A1 (fr) Derives de la purine et medicaments qui en contiennent
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
BE861451A (fr) Phenyl-5 oxazolidines et thiazolidines, et medicaments qui en contiennent
BE865870A (fr) Derives du benzimidazole et medicaments qui en contiennent
FR2316943A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2312240A1 (fr) Derives du prostane et medicaments qui en contiennent
FR2326927A1 (fr) Steroides insatures en 15 et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
BE852089A (fr) Androstenones et medicaments qui en contiennent
FR2287224A1 (fr) Derives de la pyridine et medicaments qui en contiennent
DK194776A (da) Antibakterielle midler og mellemprodukter dertil
FR2287908A1 (fr) Hydroxy-7 oestradiols et medicaments qui en contiennent
BE849346R (fr) Pyrrolidones et medicaments qui en contiennent
FR2316941A1 (fr) Pyrrolidones et medicaments qui en contiennent
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
BE788322A (fr) 3,4-dihydro-2h-isoquinoleine-1-ones et medicaments qui en contiennent
FR2347925A1 (fr) Medicaments, cosmetiques et pesticides renfermant des fluoroacyl-resorcines
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant
BE843351A (fr) Pyrrolidones et medicaments qui en contiennent
FR2283674A1 (fr) Homo-steroides et medicaments qui en renferment
FR2313066A1 (fr) Oxadiazines et medicaments qui en contiennent

Legal Events

Date Code Title Description
ST Notification of lapse